Processa Pharmaceuticals (PCSA) Institutional Ownership $0.73 -0.08 (-10.02%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Processa Pharmaceuticals (NASDAQ:PCSA)CurrentInstitutional OwnershipPercentage91.93%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$514.38KNumber ofInstitutional Sellers(last 12 months)0 Get PCSA Insider Trade Alerts Want to know when executives and insiders are buying or selling Processa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PCSA Institutional Buying and Selling by Quarter Processa Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/2/2024Spinnaker Trust76,865$26K0.0%N/A6.249% 8/5/2022Coastal Bridge Advisors LLC52,500$148K0.0%+61.5%0.331% 2/15/2022Coastal Bridge Advisors LLC32,500$159K0.0%+18.2%0.207% 2/10/2022AIGH Capital Management LLC303,703$1.49M0.5%-21.5%1.932% 1/26/2022Verdence Capital Advisors LLC63,227$310K0.0%-14.3%0.402% 10/29/2021 Janney Montgomery Scott LLC46,231$396K0.0%-18.5%0.296% 8/16/2021State Street Corp16,600$136K0.0%N/A0.107% 8/13/2021Geode Capital Management LLC37,400$306K0.0%+34.4%0.240% 8/13/2021Vanguard Group Inc.373,171$3.06M0.0%+136.7%2.397% 8/10/2021Coastal Bridge Advisors LLC27,500$225K0.0%+37.5%0.177% 8/9/2021Vectors Research Management LLC4,000$33K0.0%N/A0.026% 5/21/2021Citadel Advisors LLC13,117$143K0.0%N/A0.085% 5/19/2021Worth Venture Partners LLC90,968$942K0.5%N/A0.586% 5/18/2021Millennium Management LLC93,999$1.03M0.0%-12.0%0.606% 5/18/2021Citadel Advisors LLC13,117$143K0.0%N/A0.085% 5/17/2021Coastal Bridge Advisors LLC20,000$218K0.0%N/A0.129% 5/12/2021Northern Trust Corp12,845$140K0.0%N/A0.083% 5/12/2021Geode Capital Management LLC27,825$303K0.0%N/A0.179% 5/12/2021Essex Investment Management Co. LLC72,908$795K0.1%-2.7%0.470% 5/4/2021Commonwealth Equity Services LLC10,550$115K0.0%N/A0.068% 4/27/2021 Janney Montgomery Scott LLC63,331$690K0.0%-4.5%0.408% 2/13/2021Essex Investment Management Co. LLC74,928$494K0.1%N/A0.709% (Data available from 1/1/2016 forward) PCSA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PCSA shares? During the previous two years, the following institutional investors and hedge funds held shares of Processa Pharmaceuticals shares: Spinnaker Trust ($26K).Learn more on PCSA's institutional investors. What percentage of Processa Pharmaceuticals stock is owned by institutional investors? 91.93% of Processa Pharmaceuticals stock is owned by institutional investors. Learn more on PCSA's institutional investor holdings. Which institutional investors have been buying Processa Pharmaceuticals stock? The following institutional investors have purchased Processa Pharmaceuticals stock in the last 24 months: Spinnaker Trust ($76.87K). How much institutional buying is happening at Processa Pharmaceuticals? Institutional investors have bought a total of 76,865 shares in the last 24 months. This purchase volume represents approximately $514.38K in transactions. Related Companies Aspira Women's Health Major Shareholders Talphera Major Shareholders Aytu BioPharma Major Shareholders Kiora Pharmaceuticals Major Shareholders Indaptus Therapeutics Major Shareholders Ensysce Biosciences Major Shareholders SciSparc Major Shareholders Cyclerion Therapeutics Major Shareholders Biofrontera Major Shareholders Eagle Pharmaceuticals Major Shareholders This page (NASDAQ:PCSA) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Processa Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Processa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.